276 related articles for article (PubMed ID: 20559294)
1. BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists.
dos Santos Silva CM; Barbosa FR; Lima GA; Warszawski L; Fontes R; Domingues RC; Gadelha MR
Obesity (Silver Spring); 2011 Apr; 19(4):800-5. PubMed ID: 20559294
[TBL] [Abstract][Full Text] [Related]
2. Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels.
Ciresi A; Amato MC; Guarnotta V; Lo Castro F; Giordano C
Clin Endocrinol (Oxf); 2013 Dec; 79(6):845-52. PubMed ID: 23506485
[TBL] [Abstract][Full Text] [Related]
3. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
[TBL] [Abstract][Full Text] [Related]
4. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic cabergoline treatment and testosterone replacement on metabolism in male patients with prolactinomas.
Auriemma RS; Galdiero M; Vitale P; Granieri L; Lo Calzo F; Salzano C; Ferreri L; Pivonello C; Cariati F; Coppola G; de Angelis C; Colao A; Pivonello R
Neuroendocrinology; 2015; 101(1):66-81. PubMed ID: 25592453
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy.
Berinder K; Nyström T; Höybye C; Hall K; Hulting AL
Pituitary; 2011 Sep; 14(3):199-207. PubMed ID: 21128120
[TBL] [Abstract][Full Text] [Related]
7. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
Abdullah AR; Hasan HA; Raigangar VL
Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of obstructive sleep apnea in patients with prolactinoma before and after treatment with dopamine agonists.
Barbosa FR; Silva CM; Lima GA; Warszawski L; Domingues RC; Dominic M; Fontes R; Vieira Neto L; Gadelha MR
Pituitary; 2014 Oct; 17(5):441-9. PubMed ID: 24068456
[TBL] [Abstract][Full Text] [Related]
12. Obesity indices and major components of metabolic syndrome in young adult Arab subjects.
Al-Shayji IA; Akanji AO
Ann Nutr Metab; 2004; 48(1):1-7. PubMed ID: 14639040
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients.
Kuo PH; Kao CF; Chen PY; Chen CH; Tsai YS; Lu ML; Huang MC
J Clin Psychopharmacol; 2011 Dec; 31(6):705-11. PubMed ID: 22020349
[TBL] [Abstract][Full Text] [Related]
14. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
[TBL] [Abstract][Full Text] [Related]
15. Body fat in nonobese women with prolactinoma treated with dopamine agonists.
Naliato EC; Violante AH; Caldas D; Lamounier Filho A; Loureiro CR; Fontes R; Schrank Y; Souza RG; Costa PL; Colao A
Clin Endocrinol (Oxf); 2007 Dec; 67(6):845-52. PubMed ID: 17645576
[TBL] [Abstract][Full Text] [Related]
16. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
[TBL] [Abstract][Full Text] [Related]
17. Leptin, insulin resistance, and metabolic changes 5 years after renal transplantation.
Nicoletto BB; Souza GC; Gonçalves LF; Costa C; Perry IS; Manfro RC
J Ren Nutr; 2012 Jul; 22(4):440-9. PubMed ID: 22054874
[TBL] [Abstract][Full Text] [Related]
18. Changes in inflammatory and metabolic parameters after periodontal treatment in patients with and without obesity.
Altay U; Gürgan CA; Ağbaht K
J Periodontol; 2013 Jan; 84(1):13-23. PubMed ID: 22348694
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
[TBL] [Abstract][Full Text] [Related]
20. Maternal waist circumference and the prediction of children's metabolic syndrome.
Hirschler V; Roque MI; Calcagno ML; Gonzalez C; Aranda C
Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1205-10. PubMed ID: 18056567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
